Beiersdorf’s plans to turn back the age clock: ‘Epigenetics is not set in stone’

By Julia Wray | Published: 5-Oct-2023

Beiersdorf’s Dr Marc Winnefeld and Dr Elke Grönniger discuss the skin care specialist’s Skin Age Clock tech and its implications for NPD

You need to be a subscriber to read this article.
Click here to find out more.

Epigenetics, the branch of science that studies the interactions between environmental factors and DNA, will soon influence the skin care goods taking pride of place in our bathrooms.   

At least, that will be the case if Beiersdorf, the multinational behind Nivea, Eucerin and La Prairie, has any say in the matter. 

The Hamburg-based company – which employs around 1,000 researchers working to pinpoint the most impactful innovations – has been researching epigenetics since 2008. 

In late 2021, it received a patent for its Skin Age Clock technology, described as an “important milestone” in epigenetic anti-ageing research.

This means it has now “reached a stage of research that brings substantial epigenetic rejuvenation of skin cells within reach”, says Dr Marc Winnefeld, Head of the Applied Skin Research Department at Beiersdorf. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like